Changes in the Gut Microbiome Associated with Intussusception in Patients with Peutz-Jeghers Syndrome/Experiment 2

From BugSigDB


Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Peutz-Jeghers Polyp Peutz Jeghers polyp,Peutz-Jeghers polyp,Peutz-Jeghers Polyp,peutz-Jeghers Polyp
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Without Intussusception (NI-PJS)
Group 1 name Corresponds to the case (exposed) group for case-control studies
With Intussusception (I-PJS)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients who had undergone at least one intussusception (I-PJS)
Group 0 sample size Number of subjects in the control (unexposed) group
57
Group 1 sample size Number of subjects in the case (exposed) group
106
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
within 3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3.0

Alpha Diversity

Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 2 (D)

Description: LEfSe analysis identified the differences in abundance between I-PJS and NI-PJS patients (LDA > 3.0).

Abundance in Group 1: decreased abundance in With Intussusception (I-PJS)

NCBI Quality ControlLinks
Actinomycetota
Bifidobacteriaceae
Bifidobacteriales
Bifidobacterium
Burkholderiaceae
Faecalibacterium
Peptostreptococcaceae
Romboutsia
Lachnospiraceae UCG_004Lachnospiraceae UCG_004
BetaproteobacterialesBetaproteobacteriales

Revision editor(s): Rahila

Signature 2

Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 2 (D)

Description: LEfSe analysis identified the differences in abundance between I-PJS and NI-PJS patients (LDA > 3.0).

Abundance in Group 1: increased abundance in With Intussusception (I-PJS)

NCBI Quality ControlLinks
Blautia
Enterobacterales
Enterobacteriaceae
Escherichia/Shigella sp.
Fusobacteriaceae
Fusobacteriales
Fusobacteriia
Fusobacterium
Gammaproteobacteria
Klebsiella
Pseudomonadota

Revision editor(s): Rahila